Case study: How a holistic view was taken when exploring compliance

The challenge

Our client wanted to address the issues and barriers surrounding non-compliance with their biologic drug. The assumption going into the study was that the barriers to compliance existed among the patients themselves. We therefore employed a one-to-one methodology with patients who were recruited to represent the various stages in the patient journey as they transitioned to biologics.

Oncology in APAC (Jan 2018)
Oncology in APAC (Jan 2018)

The challenge

Our client wanted to address the issues and barriers surrounding non-compliance with their biologic drug. The assumption going into the study was that the barriers to compliance existed among the patients themselves. We therefore employed a one-to-one methodology with patients who were recruited to represent the various stages in the patient journey as they transitioned to biologics.

The solution
We felt it was important to gain the perspectives of the healthcare professional managing the patients in order to gain a more holistic view of the patient experience. In addition to the patient interviews, we also interviewed the prescribing physicians and nurses who were personally responsible for counselling and educating patients regarding biologic treatment. Through speaking to these stakeholders it became apparent that the main reasons for non-compliance lies in physicians’ perceptions of both the disease and treatment, and how these were being conveyed in what was and wasn’t being communicated to the patient.

The outputs
By gaining understanding of the patient journey and learning where the real barriers lay (i.e. with physicians rather than patients), our client was able to identify the critical issues affecting compliance in this therapy area, giving the team a new focus for their marketing strategy.

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here